インサイダーの売却・購入履歴
| 自社株取引日 | 役員・従業員名 | 役員・従業員の役職 | 株式の種類 | 売却／購入 | 株数 | 株価 |
|---|---|---|---|---|---|---|
| 2022-03-29 | SCHROEDER, MARK S | EVP, President-Diagnostics Lab | 普通株式 | 購入 | 2,356 | $277.11 |
| 2022-03-29 | VAN, DER VAART SANDRA D | EVP, Chief Legal Officer | 普通株式 | 購入 | 2,449 | $277.11 |
| 2022-03-28 | EISENBERG, GLENN A | Chief Financial Officer, EVP | 普通株式 | 購入 | 6,286 | $276.42 |
| 2022-03-28 | KIRCHGRABER, PAUL R | CEO, Covance Drug Development | 普通株式 | 購入 | 1,648 | $276.42 |
| 2022-03-28 | CAVENEY, BRIAN J | EVP, President of Diagnostics | 普通株式 | 購入 | 1,883 | $276.42 |
| 2022-03-28 | BERBERIAN, LANCE | EVP, CIO & CTO | 普通株式 | 購入 | 2,360 | $276.42 |
| 2022-03-28 | WILKINSON, PETER J | SVP, Chief Accounting Officer | 普通株式 | 購入 | 915 | $276.42 |
| 2022-03-28 | VAN, DER VAART SANDRA D | EVP, Chief Legal Officer | 普通株式 | 購入 | 1,792 | $276.42 |
| 2022-03-28 | SCHROEDER, MARK S | EVP, President-Diagnostics Lab | 普通株式 | 購入 | 1,885 | $276.42 |
| 2022-03-27 | BERBERIAN, LANCE | EVP, CIO & CTO | 普通株式 | 購入 | 5,310 | $0.00 |
| 2022-03-27 | SCHROEDER, MARK S | EVP, President-Diagnostics Lab | 普通株式 | 購入 | 4,241 | $0.00 |
| 2022-03-27 | KIRCHGRABER, PAUL R | CEO, Covance Drug Development | 普通株式 | 購入 | 3,707 | $0.00 |
| 2022-03-27 | VAN, DER VAART SANDRA D | EVP, Chief Legal Officer | 普通株式 | 購入 | 4,241 | $0.00 |
| 2022-03-27 | WILKINSON, PETER J | SVP, Chief Accounting Officer | 普通株式 | 購入 | 2,822 | $0.00 |
| 2022-03-27 | CAVENEY, BRIAN J | EVP, President of Diagnostics | 普通株式 | 購入 | 4,241 | $0.00 |
| 2022-03-27 | EISENBERG, GLENN A | Chief Financial Officer, EVP | 普通株式 | 購入 | 14,144 | $0.00 |
| 2022-03-25 | WILLIAMS, R SANDERS | Director | 普通株式 | 購入 | 572 | $272.98 |
| 2022-03-25 | WENGEL, KATHRYN E | Director | 譲渡制限付株式ユニット | 購入 | 603 | $0.00 |